Progressive familial intrahepatic cholestasis type 3 revealed by oral contraceptive pills
- 1 May 2003
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 38 (5), 693-694
- https://doi.org/10.1016/s0168-8278(03)00049-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthoodGastroenterology, 2001
- MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasisGastroenterology, 2001
- MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide TrappingPublished by Elsevier BV ,2000
- Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein traffickingHuman Molecular Genetics, 2000
- 3-hydroxy-3-methylglutaryl–coenzyme a reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in ratsGastroenterology, 1999
- Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancyThe Lancet, 1999
- Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrumMutation Research, 1998
- Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasisProceedings of the National Academy of Sciences, 1998